FDA Issues Warning and Labeling Updates for Promethazine Hydrochloride Injection Products
In an announcement targeted at Health Care Professionals, the U.S. Food and Drug Administration (FDA) has released information regarding labeling updates for products... Read more.
Narcolepsy Drugs Market Soars to $5.95 Billion by 2030: Sodium Oxybate Takes Center Stage in Global Forecast
The Narcolepsy Drugs Market is on an upward trajectory, projected to reach a substantial value of US$5.95 billion by 2030, as revealed by the latest report from... Read more.
Stuart Therapeutics Unveils Breakthrough Phase 3 Clinical Trial for Vezocolmitide, a Potential Game-Changer in Dry Eye Disease Treatment
Stuart Therapeutics, Inc. (“Stuart”), a cutting-edge biopharmaceutical company specializing in extracellular matrix-targeting peptide therapeutics for... Read more.
Acelyrin, Inc. Faces Wrath of Investors in Landmark Securities Class Action
Kessler Topaz Meltzer & Check, LLP has announced the initiation of a securities class action lawsuit against Acelyrin, Inc. (NASDAQ: SLRN). The legal action... Read more.
Drugmakers to Increase Prices on Over 500 Drugs in January
According to an exclusive report by Reuters, several major pharmaceutical companies, including Pfizer, Sanofi, and Takeda Pharmaceutical, are set to raise prices... Read more.
MiMedx Group Receives FDA Warning Letter for Axiofill; Shares Decline 7%
MiMedx Group Inc, a biopharmaceutical company, reported on Friday that it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding... Read more.
Corcept Loses Patent Dispute Against Teva, Shares Tumble
A U.S. judge ruled in favor of Teva Pharmaceutical Industries in a patent infringement lawsuit filed by Corcept Therapeutics, leading to a significant drop in shares... Read more.
McKinsey Agrees to Pay $78 Million in Final Settlement Over Alleged Role in U.S. Opioid Epidemic
Consulting firm McKinsey & Co has reached a final settlement of $78 million to resolve claims made by U.S. health insurers and benefit plans. The allegations... Read more.
Tylenol vs. Paracetamol: Unveiling the Differences and Similarities in Two Global Pain Relievers
Tylenol and Paracetamol are two widely used over-the-counter medications that share a common active ingredient: acetaminophen. While Tylenol is a well-known brand... Read more.
FDA Updates Guidance on Topical Ophthalmic Drug Quality
In a significant development for the pharmaceutical industry, the U.S. Food and Drug Administration (FDA) has made an announcement regarding the revision of its... Read more.